Case Studies
A Breakthrough Approach for MIS SI Joint Fusion 2
“The novel posteromedial to lateral technique for SI Joint fusion is a game changer”
*Consultant for SI-BONE, Inc.
- Provider
- Babajide Ogunseinde, MD*
- Speciality
- Orthopedic Spine Surgery Longview Orthopedic Clinic Association
- Facility
- Longview Orthopedic Clinic
- Bio
-
Fellowship: Spine Surgery, Harvard Medical School, Boston, MA Residency: Harvard Combined Orthopaedic Surgery, Harvard Medical School, Boston, MA Medical School: Howard University, Washington, DC Dr. Ogunseinde is a board-certified orthopedic surgeon who offers comprehensive
spine care for a full range of spinal conditions from acute injuries and degenerative conditions to more complex conditions such as adult scoliosis, spinal infections, fractures and spine tumors.
Symptomatic SI Joint Dysfunction
Patient History:
- Prior L5-S2 fusion
- Spondylolisthesis w/o myelopathy/radiculopathy in sacral and sacrococcygeal region
- 4 of 5 positive provocative test
- SI injections helped significantly with short-lived symptom improvement
Surgical Treatment:
Bilateral MIS SI joint fusion with iFuse TORQ® implants using a posteromedial to lateral technique augmenting existing S2AI stabilization.
PostOp:1
- X-ray looked good, no evidence of hardware complications
- >75% pain improvement (VAS 10/10 to 2/10 bilateral) at 3-month follow-up
1Patient results may vary
“The single midline incision posteromedial to lateral technique is revolutionary because of its minimal soft tissue trauma, short surgery time as well as easy access to both SI joints from one surgeon position"
- Babajide Ogunseinde, MD
Healthcare professionals should refer to the Instructions For Use for indications, contraindications, warnings, and precautions at https://si-bone.com/label.
There are potential risks associated with iFuse procedures. They may not be appropriate for all patients and all patients may not benefit.
For information about the risks, visit https://si-bone.com/risks.